🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT03887663
Recruiting Observational

Chinese PD Registry

NCT03887663 · tracked via the Priya Life Science China tracker
Sponsor
Xiangya Hospital of Central South University
Phase
Observational
Started
2017-02-01
Last updated
2019-12-13

Condition(s) studied

Parkinson Disease

Study summary

The purpose of the Chinese Parkinson's disease Registry (CPDR) is to develop a database of patients with Parkinson's disease in China.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients diagnosed with PD by UK Brain Bank Diagnostic Criteria and other standard criteria. Exclusion Criteria: * Lack of capacity to consent to participate in the project

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Xiangya Hospital of Central South University Changzhi Hunan Recruiting

More Xiangya Hospital of Central South University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03887663 on ClinicalTrials.gov ↗ ← All trials in China